UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.249

Sortiert nach

Re: ‘Rapid point-of-care testing for SARS-CoV-2 in a community screening setting shows low sensitivity’

Public health (London), 2021-10, Vol.199, p.e1-e1

2021

Volltextzugriff (PDF)

Initial combination therapy with saxagliptin and metformin provides sustained glycaemic control and is well tolerated for up to 76 weeks

Diabetes, obesity & metabolism, 2011-06, Vol.13 (6), p.567-576

2011

Volltextzugriff (PDF)

Addition of liraglutide in patients with Type 2 diabetes well controlled on metformin monotherapy improves several markers of vascular function

Diabetic medicine, 2012-09, Vol.29 (9), p.1115-1118

2012

Volltextzugriff (PDF)

Serum haptoglobin and C-reactive protein concentration in relation to rectal and vaginal temperature of early postpartum sows

Theriogenology, 2016-08, Vol.86 (3), p.862-867

2016

Volltextzugriff (PDF)

Saxagliptin given in combination with metformin as initial therapy improves glycaemic control in patients with type 2 diabetes compared with either monotherapy: a randomized controlled trial

Diabetes, obesity & metabolism, 2009-06, Vol.11 (6), p.611-622

2009

Volltextzugriff (PDF)

novel insulin formulation with a more rapid onset of action

Diabetologia, 2008-09, Vol.51 (9), p.1602-1606

2008

Volltextzugriff (PDF)

Effect of vildagliptin compared to glimepiride on postprandial proinsulin processing in the β cell of patients with type 2 diabetes mellitus

Diabetes, obesity & metabolism, 2013-06, Vol.15 (6), p.576-579

2013

Volltextzugriff (PDF)

Cardiovascular effects of disturbed insulin activity in metabolic syndrome and in type 2 diabetic patients

Hormone and metabolic research, 2009-02, Vol.41 (2), p.123

2009

Volltextzugriff (PDF)

Performance of blood glucose meters in compliance with current and future clinical ISO15197 accuracy criteria

Current medical research and opinion, 2014-02, Vol.30 (2), p.185-190

2014

Volltextzugriff (PDF)

Standardized modulation of the injection site allows for insulin dose reduction without deterioration of metabolic control

Current medical research and opinion, 2014-10, Vol.30 (10), p.2001-2008

2014

Volltextzugriff (PDF)

Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes

The New England journal of medicine, 2020-12, Vol.383 (23), p.2219-2229

2020

Volltextzugriff (PDF)

Performance of the continuous glucose monitoring system (CGMS) during development of ketosis in patients on insulin pump therapy

Diabetic medicine, 2006-10, Vol.23 (10), p.1124-1129

2006

Volltextzugriff (PDF)

The Barmer study: impact of standardized warming of the injection site to enhance insulin absorption and reduce prandial insulin requirements and hypoglycemia in obese patients with diabetes mellitus

Current medical research and opinion, 2014-05, Vol.30 (5), p.753-760

2014

Volltextzugriff (PDF)

The Euroschool on Exotic Beams

1st ed. 2018., 2018

Volltextzugriff (PDF)

Insulin delivery with FlexPen®: dose accuracy, patient preference and adherence

Expert opinion on drug delivery, 2008-08, Vol.5 (8), p.915-925

2008

Volltextzugriff (PDF)

Abrocitinib versus Placebo or Dupilumab for Atopic Dermatitis

The New England journal of medicine, 2021-03, Vol.384 (12), p.1101-1112

2021

Volltextzugriff (PDF)

Pioglitazone decreases carotid intima-media thickness independently of glycemic control in patients with type 2 diabetes mellitus : Results from a controlled randomized study

Circulation (New York, N.Y.), 2005-05, Vol.111 (19), p.2525-2531

2005

Volltextzugriff (PDF)

The Euroschool on Exotic Beams - Vol. 5

1, 2018

Volltextzugriff (PDF)

Sozialismus & Pädagogik: Verhältnisbestimmungen und Entwürfe

Sebastian Engelmann, Robert Pfützner / Sebastian Engelmann, Robert Pfützner

2018

Volltextzugriff (PDF)

A 26-week, placebo- and pioglitazone-controlled monotherapy study of rivoglitazone in subjects with type 2 diabetes mellitus

Diabetes, obesity & metabolism, 2012-11, Vol.14 (11), p.1000-1009

2012

Volltextzugriff (PDF)

Euglycemic ketosis in patients with type 2 diabetes on SGLT2-inhibitor therapy—an emerging problem and solutions offered by diabetes technology

Endocrine, 2017-04, Vol.56 (1), p.212-216

2017

Volltextzugriff (PDF)

Hyperons and Resonances in Nuclear Matter

The Euroschool on Exotic Beams - Vol. 5, 2018, Vol.948, p.161-253

2018

Volltextzugriff (PDF)

Pioneer Study: PPARγ Activation Results in Overall Improvement of Clinical and Metabolic Markers Associated with Insulin Resistance Independent of Long-term Glucose Control

Hormone and metabolic research, 2005-08, Vol.37 (8), p.510-515

2005

Volltextzugriff (PDF)

Successful switch from insulin therapy to treatment with pioglitazone in type 2 diabetes patients with residual β-cell function: results from the PioSwitch Study

Diabetes, obesity & metabolism, 2009-05, Vol.11 (5), p.464-471

2009

Volltextzugriff (PDF)

Pleiotrophic and anti-inflammatory effects of pioglitazone precede the metabolic activity in type 2 diabetic patients with coronary artery disease

Atherosclerosis, 2008-03, Vol.197 (1), p.311-317

2008

Volltextzugriff (PDF)

1 – 25 von 1.249

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(955)
Mit Volltextzugriff
(1.089)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(1.154)
Deutsch
(93)
Japanisch
(92)
Russisch
(7)
Französisch
(3)
Estnisch
(2)

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(566)
Humans
(327)
Physics
(301)
Life Sciences & Biomedicine
(292)
Physical Sciences
(254)
Female
(202)
Male
(189)
Middle Aged
(147)
Technology
(139)
Adult
(114)
Physics, Nuclear
(105)
Biological And Medical Sciences
(100)
Endocrinology & Metabolism
(99)
Aged
(97)
Medical Sciences
(81)
Animals
(78)
Engineering
(77)
Nuclear Experiment
(64)
Diabetes Mellitus, Type 2 - Drug Therapy
(61)
Exact Sciences And Technology
(61)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(9)

Menü

Weitere Dienste

Einstellungen

Re: ‘Rapid point-of-care testing for SARS-CoV-2 in a community screening setting shows low sensitivity’

Initial combination therapy with saxagliptin and metformin provides sustained glycaemic control and is well tolerated for up to 76 weeks

Addition of liraglutide in patients with Type 2 diabetes well controlled on metformin monotherapy improves several markers of vascular function

Serum haptoglobin and C-reactive protein concentration in relation to rectal and vaginal temperature of early postpartum sows

Saxagliptin given in combination with metformin as initial therapy improves glycaemic control in patients with type 2 diabetes compared with either monotherapy: a randomized controlled trial

novel insulin formulation with a more rapid onset of action

Effect of vildagliptin compared to glimepiride on postprandial proinsulin processing in the β cell of patients with type 2 diabetes mellitus

Cardiovascular effects of disturbed insulin activity in metabolic syndrome and in type 2 diabetic patients

Performance of blood glucose meters in compliance with current and future clinical ISO15197 accuracy criteria

Standardized modulation of the injection site allows for insulin dose reduction without deterioration of metabolic control

Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes

Performance of the continuous glucose monitoring system (CGMS) during development of ketosis in patients on insulin pump therapy

The Barmer study: impact of standardized warming of the injection site to enhance insulin absorption and reduce prandial insulin requirements and hypoglycemia in obese patients with diabetes mellitus

The Euroschool on Exotic Beams

Insulin delivery with FlexPen®: dose accuracy, patient preference and adherence

Abrocitinib versus Placebo or Dupilumab for Atopic Dermatitis

Pioglitazone decreases carotid intima-media thickness independently of glycemic control in patients with type 2 diabetes mellitus : Results from a controlled randomized study

The Euroschool on Exotic Beams - Vol. 5

Sozialismus & Pädagogik: Verhältnisbestimmungen und Entwürfe

A 26-week, placebo- and pioglitazone-controlled monotherapy study of rivoglitazone in subjects with type 2 diabetes mellitus

Euglycemic ketosis in patients with type 2 diabetes on SGLT2-inhibitor therapy—an emerging problem and solutions offered by diabetes technology

Hyperons and Resonances in Nuclear Matter

Pioneer Study: PPARγ Activation Results in Overall Improvement of Clinical and Metabolic Markers Associated with Insulin Resistance Independent of Long-term Glucose Control

Successful switch from insulin therapy to treatment with pioglitazone in type 2 diabetes patients with residual β-cell function: results from the PioSwitch Study

Pleiotrophic and anti-inflammatory effects of pioglitazone precede the metabolic activity in type 2 diabetic patients with coronary artery disease

Suchergebnisse filtern